methyldimethylaminoazobenzene has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, N; Matsushima-Nishiwaki, R; Moriwaki, H; Okuno, M; Shimizu, M; Tanaka, T; Tsurumi, H | 1 |
1 other study(ies) available for methyldimethylaminoazobenzene and cyclin d1
| Article | Year |
|---|---|
Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats.
Topics: Adenoma; Animals; beta Catenin; Blotting, Western; Carcinoma, Hepatocellular; Cell Nucleus; Cyclin D1; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Rats; Rats, Inbred F344; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |